XV Eurasian Hematology-Oncology Congress - EHOC 2024
H

Critical Re-Evaluation of Established Practices in CML Management

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Hagop Kantarjian
By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Hagop Kantarjian
75 views
September 16, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
04:16
Luke Fletcher

Efficacy and Safety of Asciminib in Ph+ CML

14:01
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Highlights in Heme Malignancies

Feat. M. Gomes da Silva
16:25
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New ELN Laboratory Recommendations for the Diagnosis …

Feat. N. Cross
19:15
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: CML - Are We Doing It Right?

Feat. J. Cortés
33:56
MyCancerHaven

Experts Discuss How They Use Asciminib in Their CML Practice

Feat. R. Vij, J. Zeidner
17:30
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Rational TKI Choice in CML

Feat. M. Deininger
12:09
Pooja Khandelwal

Treating Fibrosis and Inflammation in GvHD

17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
17:47
The University of Alabama at Birmingham School of Medicine

Treating CML Patients With TKI Resistance vs. TKI Intolerance

Feat. O. Jamy
11:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Asciminib Combined With Dasatinib and Predn…

Feat. M. Luskin
20:43
Indy Hematology Review

Controversies in the Management of CML in 2024

Feat. R. Larson
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
16:52
Winship Cancer Institute - Emory University

Updates on Myeloproliferative Neoplasms Including CML

Feat. A. Hunter
23:06
Indy Hematology Review

Understanding and Addressing the Challenges in CML in 2024

Feat. R. Larson
06:26
Akriti Jain

Managing TKI AEs in CML: Thrombocytopenia, Hypertension, Pancreatic …

08:32
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "ALLG CML13 ASCEND-CML Study - Asciminib Tre…

Feat. D. Yeung